Skip to main content
. 2022 Aug 10;44(2):308–320. doi: 10.1038/s41401-022-00941-3

Fig. 8. Schematic diagram for the role of roxadustat in NTG-induced migraine.

Fig. 8

Roxadustat ameliorated NTG-induced migraine by activating HIF-1α, which is mainly mediated by reducing NF-κB/inflammation pathway to attenuate central sensitization markers, p-ERK1/2, and c-Fos. HIF-1α activators might be potential drugs for treatment of migraine.